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ABSTRACT 
 
 
The cornea, which is key to maintaining our normal vision by refracting 
light onto the lens and retina, as well as serving as a physical barrier to protect 
our eyes from the environment, contains epithelium tissue with one of the highest 
capacities for renewal and wound healing in the body. Although many studies 
have looked at the process of wound healing in corneal epithelium, most of them 
have focused on the various ligand-receptor growth factor signaling pathways, 
and few studies have been done to study the signaling and regulations of wound 
healing that are initiated intracellularly, or those associated with electrical 
currents and channel activity. This study, therefore, aims to look at the 
hypotheses that injury to the corneal epithelium leads to the downregulation of a 
type of potassium transport channels named Kir4.1/KCNJ10, and that the 
inhibition of KCNJ10 is associated with intracellular microRNA-205 (miR-205), 
which is upregulated during injury and healing. Together, the modulations in the 
level of KCNJ10 and microRNA-205 contribute to change in the environment 
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around the wound and promote the cellular processes that allow for efficient 
corneal healing. 
To investigate the role of potassium channels and microRNAs in the 
cornea epithelium, an in-vitro model of endogenous wound healing was 
employed with human corneal epithelium cells (HCECs) serving as the primary 
model of study. Physiological injury was simulated using a scratch-wound model. 
The protein expressions for KCNJ10 and microRNA-205 were measured through 
various time points from both control and injured HCECs. The effect of two RNAi 
modulators of microRNA-205, a mimic and antagonist, and of KCNJ10 blockers 
were also tested for effects on the rate and efficiency of HCEC wound healing.  
Results indicated that the expression of miR-205 increased in scratch-
injured HCECs and that the expression of KCNJ10 decreased in wounded and 
healing HCECs. It was also shown that increasing KCNJ10 and decreasing miR-
205 both lead to delayed healing, but that blocking KCNJ10 could partially 
abolished the effect of delayed healing associated with decreasing miR-205 and 
restored the healing process. It was also shown that the 3’UTR of KCNJ10 
contains potential target sites for miR-205 binding and action. The results 
indicate that that KCNJ10 expression is negatively associated with corneal 
wound healing, and that miR-205 is upregulated upon injury in wounded corneal 
epithelium to inhibit KCNJ10 and allow for the processes of wound healing to 
take place.  
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 1 
INTRODUCTION 
 
Potassium (K+) Channels  
Potassium channels and their subunits are by far the most diverse and 
widely distributed type of ion channels found in the membranes of virtually all 
living organisms [1, 2]. Interestingly, despite their heterogeneity, the abundance 
of K+ channels on the cell membrane is very low [3]. Functionally, these 
channels can be grouped into five main classes: voltage-gated, sodium-
activated, calcium-activated, inward-rectifying, and leak channels [2, 4]. 
Structurally, potassium channels are multi-unit complexes composed of a 
tetramer of principal α-subunits that assemble to form the central conducting pore 
(Fig.1). The subunit are structurally conserved between the different classes of 
K+ channels. For example, the principal subunits of voltage-gated K+ channels 
have six transmembrane domains, while those of inward-rectifying K+ channels 
have only two [5]. Some potassium channels also have β-subunits that serve 
regulatory roles [4-6]. K+ channels participate in a wide range of physiological 
activities. In addition to their well-known role in suppressing electrical activity in 
excitable tissues, they are also involved in the regulation of epithelial transport 
that is vital for normal cellular function and metabolism [6]. 
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Inward Rectifying Potassium (Kir) Channels 
The family of so-called inwardly rectifying potassium (Kir) channels were 
discovered in 1949 by Sir Bernard Katz while studying the resting K+ 
conductance of skeletal muscles [7]. Inward rectification refers to the property of 
these channels in which current (defined here as a positive charge) is more 
easily passed inwardly into the cytosol than outwardly [8, 9]. As a class, these 
channels have wide tissue distribution in mammalian physiology, and participate 
Figure 1: Selected types of K
+
 channel subunits structure. 
 
A. Voltage-gated (Kv) subunits with six transmembrane (TM) helices. B. Inward 
rectifying (Kir) subunits with two TM helices, as well as cytosolic amino helix 
and carboxyl regulatory domain. C. Calcium-sensitive (KCa) subunits have a 
number of cytosolic C-terminal helices. Figure modified from McCoy, 2012 [5].  
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in a broad range of functions that contribute to maintaining potassium 
homeostasis and dependent processes [9-11].  
As students in physiology, our first introduction to K+ channels is almost 
always related to their role in the context of action potentials, specifically the 
importance of K+ efflux in the repolarization of excitable cell membranes post 
depolarization from Na+ and Ca2+ influx. Repolarization by K+ is caused by the 
outward flow of K+ down its electrochemical gradient in a depolarized cell, in 
order to reestablish EK, which is very negative in excitable cells. These K+ 
channels are outwardly rectifying, that is, their open probability and conduction 
increases with greater depolarization. So, in contrast to Kir channels, K+ 
channels involved in action potential repolarization are outwardly rectifying [12]. 
For this reason, the first identified Kir channels were termed “anomalous 
rectifiers” for their opposite behavior of conducting current flows that were 
reduced by membrane depolarization and increased by repolarization.  
Kir channels are often essential in regulating the resting membrane 
potential (RMP) in diverse cell types in which are they are expressed, and work 
to couple cell metabolism with membrane excitability [13]. The reversal potential 
of potassium, also called the Nernst potential, is the membrane potential at which 
there is no net flow of K+ from one side of the cell membrane to the other, in 
other words, the potential at which there is zero net flux of K+ ions. When talking 
about single-ion transport systems, the reversal potential is also equal to the 
equilibrium potential (EK), The reversal potential of any ion depends on its 
 4 
intracellular and extracellular concentrations, and is calculated with the Nernst 
equation [14].  
In general, Kir channels allow the flow of K+ ion into the cell at membrane 
potentials (Vm) negative to the K+ reversal potential (EK), thus raising the Vm back 
to its resting potential. However, when Vm is positive with respect to EK, these 
channels allow only a small flow of K+ out of the cell [14]. They conduct much 
larger inward potassium currents at membrane voltages negative to the K+ 
equilibrium potential than outward currents at voltages positive to it, even when 
K+ concentrations are equal on both side to allow K+ to move more easily into 
rather than out of the cell. The conductance, or the ease with which the current 
can pass, of all Kir channels except for Kir7.1 increases as extracellular K+ 
concentration [K+]o increases [9, 11, 15]. The unique property of inward 
rectification is caused by the blockade of the channel pore by divalent 
intracellular cations, like magnesium and polyamines, being driven outwardly by 
membrane depolarization[9, 16].  As mentioned, increasing extracellular [K+]o 
relieves rectification, explained by K+ binding to external sites and displacing the 
Mg2+ block [17]. 
 
Classification and Structure of Kir Channels  
Kir channels are encoded by the KCNJ gene family, and fifteen KCNJ 
genes have been identified to date, classified into seven subfamilies (Kir1.x to 
Kir7.x) and four functional groups [8, 9]. The first group, Kir2.x, are referred to as 
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the classical Kir channels, and are constitutively active. Kir3.x constitute the 
second group, called G protein-gated Kir channels due to their regulation by G 
protein-coupled receptors. ATP-sensitive K+ channels (Kir6.x) make up the third 
group, and are tightly regulated by ATP and cellular metabolism. The fourth 
group, which includes Kir1.x, Kir4.x, Kir5.x, and Kir7.x, are referred to as K+ 
transport channels [9].  
Structurally, all Kir channel are composed of α-subunits that each have 
two membrane-spanning helical domains (M1 and M2), cytoplasmic amino and 
carboxyl terminal domains, and an extracellular region called the P-loop 
containing the K+ selectivity sequence that folds back to form the pore-lining  (Fig 
2A) [6, 8, 9, 18]. In contrast to the simple two transmembrane α-subunits of Kir 
channels, voltage-gated potassium channels subunits typically have six 
transmembrane (M1-M6) domains [19]. The first crystal structures of Kir channel 
were obtained from bacteria, showing the channels to be made from dimers of 
the subunits (Fig 2B) [20]. In humans, Kir channels are instead composed of 
tetramers (both homotetramers and heterotetramers) of these α-subunits [8, 9].  
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While all Kir channels are better at passing K+ into the cell than out, they 
vary in the degree, or strength, of rectification. Weaker Kir channels (Kir1.x, 
Kir4.x, Kir5.x and Kir7.x subfamilies) such as Kir1.1 (ROMK) allow for more 
outward current at depolarized potentials than stronger rectifiers like Kir2.x and 
Kir3.x, which allow very little outward K+ flow [8, 17]. The variation in strength 
Figure 2: Kir subunit and channel structure. 
 
A. Kir subunit all contain intracellular amino (N) and carboxyl (C) termini, two 
transmembrane segments (M1, M2), a pore-forming P-loop and K+ selectivity 
sequence (S). B. Bacterial Kir channel formed as a dimer of two subunits. 
Figure modified from Xie et al, 2007 [20].  
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stems from the presence or absence of a negatively charged residue in the M2 
domain known as the “rectifier controller”, as well as from varying channel 
sensitivity to intracellular polyamine blockers like spermine and spermidine [17]. 
Strong rectifiers are expressed in excitable cells, like cardiac myocytes or 
neurons, where they tend to hyperpolarize the membrane potential. Kir2.x 
channels, from example, control the resting voltage in many cell types/control of 
currents in ventricular fibrillation [19, 21]. Weaker rectifiers, on the other hand, 
are more commonly found in non-neuronal cell types like the epithelia and glial 
cells [12, 16].  
As mentioned, a variety of signals and modulators serve to regulate the 
members of the Kir family, including intracellular ions, G protein subunits, Gq-
coupled receptors, pH, ATP hydrolysis, and various protein kinases [9, 22-24].  
Protein kinases A and C (PKA and PKC) for example, have been shown to 
modulate Kir activities [9]. Phosphoinositides, in particular, are essential 
cofactors for all known eukaryotic inward-rectifiers. Phosphatidylinositol 4,5-
bisphosphate (PIP2), which serves as the substrate for phospholipase C (PLC)-
mediated hydrolysis into diacylglycerol and inositol triphosphate, is required by all 
Kir channels to maintain normal function, and obliteration of Kir channel activity is 
observed in the complete absence of PIP2 [9, 24-26]. 
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Kir4.1 (KCNJ10, Kir1.2, BIRK10, KCNJ13-PEN, SESAME) 
Kir4.1/KCNJ10, also known as Kir1.2, BIRK10, KCNJ13-PEN, and 
SESAME as it was independently discovered by different researchers, is a 
member of the Kir channel family which was first described in 1995 by Takumi et 
al [25]. The Kir4.1 channel subunits are encoded by the KCNJ10 gene, located 
on a 2.5-Mb segment of chromosome 1q23.2–23.3. [27, 28]. Kir4.1 can form both 
homometric channels as well as heteromeric channels in conjunction with Kir5.1 
and as some have suggested, Kir2.1 [23, 25, 29]. Kir4.1 homomers have high 
open probability (70–80%), making them weaker rectifiers than their heteromers 
with Kir5.1 [9, 25]. 
Interestingly, Kir4.1 channels have the strongest affinity for PIP2 out of all 
the Kir channels [9, 24]. They are strongly inhibited by PKC activation, and highly 
sensitive to intracellular pH and extracellular [K+], with physiological Kir4.1 
channels having their maximal conduction at a pH of 7.5 and channel activity 
inhibited at an acidic pH of 6 [25, 30]. However, Rojas and others have 
suggested that sensitivity to PKC and pH regulation are dependent on subunit 
configuration, and that the Kir4.1 homomer has lower pH sensitivity and is less 
subjected to inhibition by PKC phosphorylation [9, 23, 31].  
 
Role of Kir4.1 in excitable and non-excitable tissues 
Functionally, Kir4.1 is expressed in both excitable and non-excitable tissue 
types. It is the principal K+ channel expressed on the retinal Muller cell, as well 
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as brain astrocytes and satellite glial cells [27, 32, 33]. The most well-studied 
function of Kir4.1 is likely its role in a process called “spatial buffering” in  
astrocytes and glial cells. By definition, the process refers to spatial redistribution 
of excess extracellular K+ post synaptic activity [34]. As extracellular K+ 
accumulates after action potentials and membrane repolarization, glial cells rely 
on Kir4.1 dependence of [K+]o and membrane potential for K+ uptake in regions 
of accumulated [K+] and to redistribute the K+ ions from these regions of elevated 
[K+]o to regions where [K+]o is low [12, 35]. This allows for the low [K+]o 
concentration to be maintained in extracellular space around neurons and 
synaptic clefts.  
In neuronal tissues, Kir 4.1 has also been noted for its roles in maintaining 
retinal physiology, oligodendrocyte development and myelination, generation of 
the endocochlear potential of the inner ear required for hearing, as well as 
protecting astroglial cells against swelling after severe brain damage or injury [9, 
25, 30, 36]. Furthermore, loss of glial-associated Kir4.1 function has been 
implicated in diseases ranging from amyotrophic lateral sclerosis (ALS) to retinal 
degeneration, as well as glial cell cancers [12, 37].  
In non-excitable tissues, Kir4.1 is most notably expressed in the 
basolateral epithelium of the distal convoluted tubules (DCT). Similar to its role in 
excitable tissues, Kir4.1 maintains the negative membrane potential by recycling 
potassium and driving ion pumps and exchangers, most importantly the primary 
active Na-K-ATPase pump [27, 30]. In gastric parietal cells, Kir4.1 has been 
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found to colocalize with the apical H-K-ATPase, and functions to provide K+ for 
the pump that secretes protons in exchange for K+ ions. [9]. 
 
Specific Kir Channelopathies  
Many different disorders have been tied to mutations and dysfunctions of 
Kir channels, with many being inherited diseases that affect primarily renal, 
pancreatic or cardiac function [4, 13, 38]. For example, Kir 1.1 dysfunction is 
associated with Bartter’s syndrome type III, which is characterized by salt-
wasting, hypokalemia and metabolic acidosis. Kir 6.2 is associated with familial 
persistent hyperinsulinemic hypoglycemia of infancy, a disorder characterized by 
unregulated insulin and severe hypoglycemia [39]. Table 1 provides a glimpse 
into the spectrum of Kir channelopathies in humans. 
 
Table 1. Disorders of human Kir channel dysfunction  
After Pattnaik 2012 and Hibino 2010 [9,11] 
Channel Associated Disease(s) 
Kir1.1 Bartter’s syndrome (Type II), Hyperprostaglandin E syndrome 
Kir2.1 Andersen syndrome, Short Q-T syndrome 
Kir4.1 Generalized seizures, SeSAME syndrome 
Kir6.2 
Permanent Neonatal Diabetes Mellitus (PNDM),  
DEND syndrome (developmental delay, epilepsy, and neonatal 
diabetes) 
Kir7.1 Snowflake vitreoretinal degeneration 
Kir7.2 Leber's congenital amaurosis 
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Various mutations of KCNJ10, the coding gene for Kir4.1, have recently 
been found to cause a specific disorder in humans termed EAST/SeSAME 
syndrome by different groups, characterized mainly by epilepsy, mental 
retardation, ataxia, deafness, and renal tubulopathy/salt-wasting [27, 28, 30]. The 
mechanism, in short, involves prolonged basolateral depolarization in key cell 
types (DCT renal epithelium and glial cells) caused by the absence or 
dysfunctional Kir4.1 [40, 41]. That the disorder is characterized by a constellation 
of seemingly unrelated multi-organ dysfunctions further indicates that Kir4.1 
channels play an important role in maintaining not only potassium homeostasis, 
but also the transport of other ions in various cell types [13]. Case in point, 
patients with  the disorder exhibit not only K+ and Na+ imbalance, but also 
impaired H+, Cl- and Mg2+ transport, which results in hypomagnesemia, 
hypokalemia, and metabolic alkalosis in the kidneys [13, 28, 41].  
Although Kir4.1, as well as other Kir channels are well-studied for their 
role in ion conductance and electrophysiology in a selection of neuronal tissues 
like glial and Mueller cells, as well as in important secretory organs like renal and 
gastric epithelium, its role in other, perhaps more mundane, cellular processes 
like migration and proliferation in non-excitable epithelium is virtually unexplored. 
Here we chose to examine a possible role for Kir/KCNJ in human corneal 
keratinocytes, a representative type of non-keratinized epithelial cells. 
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Corneal Epithelium and Wound Healing 
The cornea is the transparent, outer cover of the eye that functions both to 
property reflect the light entering the eye and to prevent harmful, external agents 
like dust from entering the eye [42]. The human corneal epithelium consists of 5-
7 layers of cells about 50um thick, and express a wide array of ion channels, 
transporters and pumps [43]. Ion transport across the corneal epithelium 
generates and maintains a transepithelial potential difference (TEPD) of ~25–35 
mV, with the outer side negative [44, 45]. Normally there is a net inward flow of 
sodium to the basal side and outward flow of chloride ions to the apical (tear) 
side [42, 44, 45].  
One of the notable properties of corneal epithelium is its remarkable 
capacity for renewal, and post-injury regrowth. In normal cornea, cellular turnover 
is seen by continual apoptosis of older cells of the superficial epithelium, and its 
replacement by the migration and differentiation of younger cells from  basal 
layers [46-48]. Similarly, wound healing is dictated by three continuing events: 
cell migration from surrounding basal epithelium, cell proliferation, and cell 
differentiation into stratified epithelium [42, 49]. Even when a large portion of the 
central corneal epithelium was experimentally removed by a diamond burr, 
wound closure was observed by 24 hours, with normalization of the epithelium 
observed by 48 hours [50].   
Studies into the process of corneal and epithelial wound-healing in general 
have revealed a host of different growth factors, cytokines, and receptors as 
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being involved in the process. One of the most important components is the 
epithelial growth factor receptor (EGFR) and its stimulation, which has been 
shown to promote all three aspects of corneal wound healing (migration, 
proliferation, and differentiation) [42, 51]. Other important growth factors include 
those of the transforming growth factor (TGF) family, keratinocyte growth factor 
(KGF), fibroblast growth factor (FGF), insulin-like growth factor (IGF), as well as 
fibronectin, retinoids, interleukins among others, all of which regulate the 
inflammation, growth, migration, adhesion, and differentiation during healing [49, 
52]. These growth factors act by membrane stimulation of signaling pathways 
that leads to downstream activation of various growth regulating proteins in the 
cytosol and nucleus. Two important pathways are the mitogen-activated protein 
kinase (MAPK) pathway, which leads to the phosphorylation of ERK, as well as 
the phosphatidylinositol 3-kinase (PI3K) pathway, whose activation leads to the 
phosphorylation of Akt [46, 53]. Both of these pathways can be stimulated via 
EGFR activation, as shown in Figure 3 [54]. 
 14 
 
  
 
Despite the fact that corneal cells possesses remarkable regenerative and 
healing efficiency and capacity, damage to the cornea, whether due to infection 
or the dysfunction, is a leading cause of blindness worldwide [42]. Over the 
years, dedicated research has lead to the discovery of a wide array of signaling 
Wound	  Healing 
Migration 
  Proliferation 
Figure 3: EGFR-mediated Pathways in Corneal Wound Healing. 
 
Both epithelial cell migration and proliferation are required for wound healing. 
The MAPK and PI3K pathways can both be turn on via receptor activation of the 
epithelial growth factor receptor (EGFR). Phosphorylated pAKT and pERK 
become active and promote the processes involved in corneal wound healing. 
Figure modified from Siegelin, 2011 [53]. 
Apoptosis 
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pathways and cytokines that contribute to wound healing. However, while ligand-
receptor activation of signaling pathways is vital in proper cellular healing, the 
role of other membrane-associated proteins and processes in contributing to the 
healing environment in the cornea epithelium post injury has largely been 
overlooked. In particular, one understudied area is how plasma ion transport and 
ion currents change following an injury, and whether these changes can affect 
the healing capacity of the corneal epithelial tissue.  
 
Electric Fields in Corneal Wound Healing  
Endogenous wound electric fields were determined  more than 150 years 
ago by the German physiologist Emil Du-Bois Reymond [55]. To clarify, while a 
current refers to the flow of electric charges (due to ion movement), an electric 
field (EF) refers to the force/influence that is generated by charges on other 
surrounding charges – how different ions interact [43]. Endogenous EFs occur in 
cells due to the presence of charged particles and asymmetric ion transport that 
together produce electric current flow [56, 57]. At wounds, the normal ion flow is 
altered due to disruption of cellular membranes, junctions, and layers, and the 
resultant ion leakage and flow can produce strong EFs that can provide signals in 
damaged tissues to initiate and guide cell migration and proliferation [43-45, 58, 
59]. Many of aforementioned growth factors and cytokines that control healing 
are shown to affect ion fluxes, and therefore the EFs, of corneal epithelial cells, in 
addition to mechanical forces, ATP metabolism, and UV radiation [46, 49, 60].  
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By studying the effects of these factors and their modulation on the TEPD 
and currents, we can potentially learn to control the initiation and rate of wound 
healing. For example, ascorbic acid, which is more concentrated in the corneal 
epithelium than in any other tissue in the body, is known for protecting against 
corneal ulcerations and perforations after alkali eyes burns as well as enhancing 
healing [61]. Ascorbic acid was recently shown to act, at least partially, through 
increasing the TEVD and current of the wounded cornea [44].  
 
Role of Potassium Current and Transport in Wound Healing 
If electrical potentials play a role in healing, then the potassium current, 
key to maintaining membrane potentials in so many cell types, must also be 
involved. Previous studies on the corneal epithelium in animal models have 
found chloride to constitute the major apical conductance, while K+ conductance 
dominates the basolateral membrane [62]. Related transporters, like the K+/Cl- 
symporter in corneal epithelium, have been associated with growth factor and 
EGFR activation under wounding conditions [63, 64]. Various patch clamp 
experiments have also shown K+ to be the major current component of the basal 
corneal epithelial cells, and that K+ is the main determinant of the resting 
potential of corneal epithelium [65]. Inward rectifying Kir channels, in particular, 
are well documented to be essential regulators of resting cell membrane 
potentials in several cell types, including human corneal epithelium [66].  
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Furthermore, multiple studies on wound electric fields have shown that the 
K+ current is inhibited to prevent the loss of intracellular K+ during wound 
healing, and that this inhibition is associated with the sustained cellular 
depolarization observed in wounded cells [43, 55, 65, 67, 68]. Chifflet et al. have 
published several studies, most of which use bovine corneal endothelial (BCE) 
cells, to show that wound-specific depolarization can mediate distinct cytoskeletal 
changes associated with healing, and can increase the overall rate of wound 
healing [69-71].  
Although the general trends in potassium current and associated changes 
in membrane potential after injury have gathered some interest, research that 
focus on the role of K+ channels, including Kir channels, in regulating K+ current 
during healing is more limited. One such study by Olsen et al., show that Kir4.1 
expression, as well as the inward-rectifying current associated with it were 
decreased in glial cells following acute injury, while the currents of two other 
types of K+ channels, the fast-activating outward rectifier (Ka) and the delayed 
rectifier (Kd), were both upregulated. The combination of which lead to increased 
glial proliferation and healing [12].  
 
MicroRNA and Associated Small-RNAs 
 MicroRNAs (miRNAs) are a class of endogenous, small, non-coding RNAs 
that function to silence gene activity by blocking the translation of its target 
mRNA transcripts through binding to the 3’-untranslated region (UTR) of target 
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mRNA [50, 72]. While the specific functions of the majority of miRNAs discovered 
to date remain unknown, miRNAs are known to be involved in a wide range of 
processes - from cell migration, differentiation, stress responses, stem cell 
regulation, and cancer [73].  
It is important establish the difference between miRNAs and two other 
classes of small RNA molecules. First, miRNAs are endogenous single-stranded, 
with imperfect complementarity to its mRNA targets, and act to inhibit the 
translation of mRNA. The second class is the small interfering RNA (siRNA). 
siRNAs can be endogenous or exogenous, and unlike miRNA, they are double-
stranded, can form perfect complements to their target mRNAs, and act to cleave 
mRNA. Importantly, siRNAs regulate the same gene (mRNA) that expresses 
them, while miRNAs regulate genes other than the ones that express them and 
are capable of having multiple mRNA targets [74].  The third type of small RNA 
molecules is called antagomirs, which are exogenous, biochemically-synthesized 
oligonucleotides that can efficiently and lastingly silence specific endogenous 
miRNAs by binding to them, and can therefore be used to alleviate the miRNA 
inhibition of translation [75]. SiRNAs and antagomirs are important tools in RNAi 
technologies, which are by now commonly used in molecular laboratories. 
 
Ocular MicroRNA Expression and Role in Wound Healing 
Of more than 100 miRNAs discovered from mice and humans, at least 30 
showed varying degrees of tissue specificity, including six that show specificity in 
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the eye [50, 76]. Two of them, miRNA-184 (miR-184) and miRNA-205 (miR-205), 
show further spatial specificity within the eye and cornea. The most abundant 
corneal epithelial miRNA, miR-184, although the most abundant of corneal 
miRNAs, is found only in the basal layers, and absent in the limbal and 
conjunctival epithelia as well as the epidermis. MiR-205, the second most 
abundant corneal epithelial miRNA, is expressed in all layers of the corneal, 
limbal, and conjunctival epithelia [50, 73].  
The spatially differentiated expression profile of ocular miR-205 and miR-
184 lends credibility to the idea that these two miRNAs may play roles in 
physiological processes that differentially involve these regions - processes like 
wound healing. Ryan et. al found that in cornea epithelium 24 hours after injury, 
miR-184 is strongly expressed adjacent to the wound, but absent from the re-
epithelializing wounded region, while in the same cornea 48 hours after 
wounding, miR-184 was observed in both the newly formed epithelia and 
adjacent unwounded epithelia (Fig.4, A-D). The results strongly suggest that 
miR-184 is downregulated during the early stages of healing [50]. 
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MicroRNA-205, which has broad expression across epithelial cell types, is 
likely involved in both epithelial development and maintenance. Due to this, 
research into miR-205 have largely focused on its role in regulating cell migration 
and proliferation in tumor cells [73]. Despite this, only a few endogenous mRNA 
targets of miR-205 have been studied, despite its broad expression across the 
epithelia of different organs. Greene et al. reported that in mammary epithelial 
progenitor cells, miR-205 targets Atp1a1, a subtype of Na+-K+-ATPase whose 
A B 
C D 
Wounded region Unwounded (adjacent)  
24hr 
48hr 
Figure 4: MicroRNA-184 Expression in Corneal Epithelium 
The figure shows two adjacent regions of the same cornea at 24hr and 
48hr post-injury, in-situ hybridized with a probe for miR-184. The (c) 
denotes the corneal epithelium layer. A. No miR-184 is detected in the 
wounded (re-epithelializing) region 24hr post-wound. B. MiR-184 is 
expressed in the adjacent, unharmed epithelium 24hr post-wound. C-D. 
Strong expression of miR-184 in both wounded and unwounded region 
48hr post-injury. The results indicate an initial downregulation of miR-184 
after corneal epithelial injury. Figure modified from Ryan, 2006 [50].   
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expression was downregulated when miR-205 was overexpressed [72]. Yu et al. 
have reported a possible role for miR-205 in corneal epithelial migration post 
injury through targeting and downregulating the lipid phosphatase 
phosphoinositide 5’-phosphatase 2 (SHIP2) [73].  
 
Potassium Channels as Targets of MicroRNA Inhibition  
Previous studies have pointed to pathways involving microRNA mediation 
of inward rectifying potassium channel activity. Lin et al. showed that miR-802, 
expressed in renal collecting ducts, could mediate the weak rectifier Kir1.1 
(ROMK, KCNJ1) channel by targeting and suppressing caveolin-1, leading to 
increased membrane expression of Kir1.1 [77]. The transcripts of Kir2.1 (KCNJ2) 
and Kir2.2 (KCNJ12), two other K+ inward rectifiers, were both predicted as 
targets of brain-specific miR-132 based on their 3-UTRs recognition sites, and to 
play a role in the regulation of the circadian rhythm [78] and cellular excitability. 
Kir2.1 has also been shown to be the post-transcriptional target of muscle-
specific miR-1, whose expression is associated with the development of irregular 
heart rhythms [79].  
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Research Aims 
 
Given all of the aforementioned background regarding the roles of 
potassium transport and miRNA in mediating corneal epithelial healing, the 
objective of this study was first to examine potential Kir-channel associated 
mechanisms in the regulation of corneal epithelial injury. Our focus turned to a 
explored the potential link between Kir potassium channels and ocular-specific 
microRNAs in an in-vitro model of endogenous corneal wound healing using 
HCECs.  
 
Specifically we examined,  
1) If KCNJ10 mRNA is expressed in healthy and scratch-wounded HCECs.  
2) If endogenous miRNA-184 and miRNA-205 are expressed in cultured HCECs. 
3) If the sequence of KCNJ10 is a target match for ocular miRNAs.  
4) If KCNJ10 and miRNA-205 affect the rate of in-vitro corneal wound healing 
post scratch-injury model.  
5) How KCNJ10 and miRNA-205 regulate with each other to exert their effects on 
wound healing. 
 
We hope this work can shed light on the diversity of the types of mediatory 
and regulatory components available to cells in the control of complex processes 
like wound healing. 
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MATERIALS AND METHODS 
 
Human Corneal Epithelial Cells   
Primary HCECs (PCS-700-010ml) were obtained from American Type 
Culture Collection (ATCC), and grown in 4mL of medium in T-25 culture flasks 
pre-coated with 1mL fibronectin (FNC) Coating Mix from AthenaES. The culture 
medium was obtained from Lonza (Clonetics KGM-2 Keratinocyte Growth 
Medium-2) with the following growth promoting factors added separately: BPE, 
hEGF, Insulin, Hydrocortisone, GA-1000, Epinephrine, and Transferrin. The cells 
were subpassaged upon reaching >70% confluence by the following method: 
after vacuuming old media, 4mL trypsin was added to the flask to detach the 
adherent cells. Once suspended, the cells were centrifuged at 1600rpm for 2min. 
The cell pellet was reconstituted with appropriate aliquot of medium and 
resuspended and seeded into a new FNC-coated culture flask. Cells were kept at 
37°C with 5% CO2. Fresh medium was provided every one-two days. 
 
RNA Extraction  
RNA from cultured HCECs was extracted with the miReasy Mini kit from 
Qiagen. First, 700µl QIAzol lysis buffer was added to HCECs after removing 
growth medium. Using a rubber cell scraper, the lysate was collected into 1mL 
RNase-free microcentrifuge tubes, and briefly vortexed. 140µL of chloroform was 
then added to each tube. The samples were let to stand for 2-3 min at room 
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temperature, then centrifuged at 12,000rpm for 15min. The supernatant was 
transferred to a new tube, and mixed thoroughly with 1.5X volume of 70% 
ethanol. Samples were transferred to RNeasy mini spin columns and centrifuged 
at 8000 rpm for 15sec, washed once with 700µl RWT buffer, and twice with 500µl 
RPE buffer, with 15sec spin at 8000 rpm after each wash. The RNA was eluted 
into fresh, labeled tubes with 30µl RNase-free water. The extracted RNA was 
then quantified by a spectrophotometer, and stored at -70°C.  
 
Reverse Transcriptase Polymerase Chain Reaction (RT-PCR)  
RT-PCR allows for the reverse transcription of extracted RNA into its 
complementary DNA (cDNA) by using the enzyme reverse transcriptase and 
oligonucleotide hexamer primers (dT primers). Using 0.6ml sterile eppendorf 
tubes, each reaction sample mix (20µl total) contained 4µl of 5X Reaction mix, 
2µl Maxima enzyme mix, 2µl 10X poly(A) polymerase buffer, 0.1mM ATP, 1µl 
poly(A) polymerase, 1µM RT-primer, 4ug of the extracted RNA, and the 
remaining volume in RNase-free water. Reaction mix, enzyme mix, poly(A) and 
buffer were provided by a Maxima First Strand cDNA kit (Fisher Scientific). 
Samples were incubated in the thermocycler at 25°C for 10 min, then 50°C for 30 
min, and 85°C for 5 min in order to inactivate RT enzymes. At this point the 
cDNA templates were prepared and kept at 4°C until amplification using qPCR. 
Table 2 lists the sequences of RT-primers used.  
 
 25 
  
 
 
   
Quantitative Real-Time Polymerase Chain Reaction (qPCR) 
12.5µl of 2x Brilliant II QRT-PCR SYBR Green Low ROX Master Mix 
(containing Taq DNA polymerase, dNTPs, MgCl2 and DNA polymerase buffers) 
was combined with 250nM forward and reverse primers, 50ng cDNA samples 
from the above RT reaction, and enough nuclease-free water to make 25ul total 
volume. PCR tubes were briefly vortexed and centrifuged for 30 seconds to spin 
down the sample. The thermocycler conditions were as follows: 95°C for 15min, 
followed by 40 cycles of 95°C for 30s, and 60°C for 1 min. After completion, an 
analysis of the melting curve was conducted to ensure specific amplification for 
all PCR products. U6 was used as the housekeeping reference gene for 
normalization. The relative expression of target genes and significance was 
determined based on the the 2-ΔΔCt method [80, 81]. Table 3 provides the 
sequence of all PCR primers and their melting temperature (Tm).  
 
 
 
Table 2. Reverse Transcriptase PCR primers.  
 
Amplicon RT Primer Sequence 
KCNJ10 5’-CCAAGGTGTATTACAGTCAGACC-3’ 
miR-205 5’-GTTTTTTTTTTTTTTTCAGACTCC-3’ 
miR-184 5’-GTTTTTTTTTTTTTTTACCCTTAT-3’ 
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Table 3. Quantitative PCR Primers.  
 
Amplicon 
(Tm) 
Primer Type 
 
Primer Sequence 
 
miR-205 sense: 5’-CTCTTGTCCTTCATTCCACC.  
(56.0°C) antisense: 5’-GTTTTTTTTTTTTTTTCAGACTCC. 
miR-184 sense: 5’-TAAGTGTTGGACGGAGAACTG. 
(56.5°C) antisense: 5’-GTTTTTTTTTTTTTTTACCCTTAT. 
U6 sense: 5’-CTCGCTTCGGCAGCACATA. 
(59.0°C) antisense: 5’-ATATGGAACGCTTCACGAATT. 
 
 
Cell Lysis and Protein Extraction  
HCECs were grown to a confluent (~90%) monolayer in 1ml of medium 
per well of a polylysine-coated 12-well cell culture plate. After removing the 
medium, the cells were washed once with 1x PBS. Cells were then lysed using 
100µl per well of ice-cold radioimmune precipitation assay (RiPA) buffer (25mM 
Tris-Cl, pH 7.4, 150mM NaCl, 50mM KCl, 1% SDS, 2mM EDTA, 0.5% glycerol, 
50mM NaF) with 1: 100 (v/v) dilution of the proteinase inhibitor and phosphatase 
I and II inhibitor mixture. Lysed cells were briefly vortexed to mix and placed on 
ice for 15 min, spun down at 13,000 rpm for 15 min. The pellet was discarded 
and the protein lysate kept for Western blot analysis.  
 
SDS-PAGE and Analysis by Western Blot 
Preparation for Western blot began with combining in 2 mL tubes 20 µg of 
the protein lysate with 400mM DTT in 2X sample buffer. The mix was then boiled 
in water for 5 min. and loaded into SDS-PAGE gel (% depending on sample 
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protein size). After running the gel at 180V, proteins were transferred to pre-wet 
nitrocellulose membranes, using cold tank buffer (48mM Tris, 39mM glycine, 
20% methanol and 0.0375% SDS) at 100W for 1 hour. The membrane was then 
incubated in LICOR blocking buffer for 1 hour at room temperature, and 
subsequently probed with the appropriate primary antibody from 90min at room 
temperature to overnight (at 4°C if left for incubation overnight). Incubation with 
the primary antibody was followed by three times with 0.01% Tween-20 in PBS 
for 5min per wash. The secondary antibody (680RD Goat Anti-rabbit IgG and/or 
800CW Goat Anti-Mouse IgG, both from IRDye by LI-COR) incubation was 1 
hour at room temperature, with cover on. After three more washes in 0.01% 
Tween-20 in PBS for 5 min each, the membrane was scanned with the Odyssey 
imaginer. Band densitometry and relative protein expression was quantified using 
NIH’s ImageJ program.   
  
Scratch Wound Assay  
Scratch wound assay was performed based on protocols from Liang and 
Cory [82, 83]. HCECs were seeded into a FNC pre-coated 12-well plate and left 
to grow to confluency for 24 hours prior to treatment. Check for cell confluence of 
by light microscopy before initiating protocol. To imitate in vivo wounding 
conditions, two linear scrapes were made in a crossing motion using sterile 10µl 
ultrafine micropipette tips from Fisher Scientific. The width of the linear injury 
(bared) area was approximately 1.0 mm. The time immediately following 
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scratching was considered to be the starting time point. Images at set time points 
thereafter were captured with a camera-equipped inverted microscope (Carl 
Zeiss). Rate of healing was measured as the percentage change in the injury 
area over the time since injury.  
 
Lentiviral Transfection of siRNA and Antagomir  
pSPAX2 was used as the packaging plasmid, and pMD2 as the envelope 
plasmid. Construct plasmids used were both from Qiagen – one containing a 
miR-205 mimic and the other an miR-205 antagomir. HEK293 were used as 
packaging cells, and were grown to confluency in a T-75 flask prior to 
transfection. Each flask was cotransfected with 10mg of construct plasmid, 6µg 
pSPAX2, and 3µg pMD2; along with 1ml of optiMEM reduced serum medium and 
45µl of Turbofect transfection reagent. Leave flask in culture incubator overnight 
and change the medium after 24 hours. Collect the medium, which contains the 
lentiviral particles, on day 2 or 3 post transfection. Purify the particles by filtering, 
and then pellet the particles by centrifuging at 10,000 rpm for 2 hours. 
Resuspend the pellet in keratinocyte medium and evenly apply to HCEC flasks. 
Return transfected HCECs to incubator.  
 
Potassium Channel Blockers 
Given that studies showing electric current and flux has active and crucial 
role in epithelial response to cornea injuries, and that the abnormal K+ channel 
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expression and dysfunction can lead to the impaired wound healing in multiples 
organs and cell lines Over the years, a variety of natural and synthetic 
modulators of potassium channels have been found, including many blockers 
and openers that were discovered through the search for pharmaceutical agents 
against seizures, arrhythmia, and diabetes [3].  Two common K+ channel 
inhibitors tetraethylammonium (TEA) and 4-aminopyridine (4-AP), while effective 
for Kv channels, have little effect on Kir channels [9]. The cation Ba2+ is the most 
frequently used blocker of Kir channels. It is relatively Kir-specific at µM 
concentrations, though significantly high concentrations will also block Kv 
channels. Cs+ is also used as a blocker, but is less specific than Ba2+ for Kir 
inhibition [12]. Tertiapin, a peptide isolated from honeybee venom, is also an 
effective Kir channel blocker [84]. 
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RESULTS 
 
KCNJ10 is expressed in HCECs and its expression is altered in in vitro 
scratch-injured HCECs.  
Using the protocols described in the previous section, we obtained protein 
samples from control wells of HCECs and from the wells where scratch-wounds 
had been made 24hr prior to mimic epithelial wounding.  Using rabbit polyclonal 
antibody for KCNJ10 (EMD Millipore), we observed the expression of KCNJ10 
monomers (~34kD) in both control and wounded HCECs on our Western blot. In 
injured HCECs, the level of expression is clearly lower than compared to control 
cells. Upon further analysis of our blot by densitometry, we found the variable 
protein expression of KCNJ10 in control and scratch-wounded HCECs to be 
statistically significant. Figure 5 shows the blot (top) and graph (bottom) of the 
relative expressions of KCNJ10, note that the relative expression of KCNJ10 in 
wounded HCECs is significantly lower than that of the control cells at 24 hours 
after injury.    
 
 
 
 31 
 
 
 
 
 
 
 
Figure 5. KCNJ10 expression in control and injured HCECs. 
 
Western blot and graph of normalized expression (to tubulin) showing that the 
monomeric KCNJ10 protein is expressed in HCECs and that its expression is 
significantly decreased in injured HCECs 24 hours after scratch wounding. 
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The miR-205 expression is increased in scratch-injured HCECs, while miR-
184 expression is unchanged in injured HCECs.  
 We measured the genomic expression of the two most abundant 
microRNAs of the cornea – miR184 and miR-205 by reverse transcriptase and 
quantitative PCR – between control and injured HCECs using RNA extracted 
from both groups after 1 hour and 24 hours. We found that levels of miR-205 
expression increased in injured HCECs as early as 1 hour after scratch wound, 
by an average of 57% ± 9.4% (mean ± SD, n=4), and remained higher 24 hours 
(96% ± 15%) post injury. Expression of miR-184 on the other hand, did not 
significantly differ between wounded and control HCECs at 1 hour and 24 hours. 
Graphs show miR-205 (Fig. 6) and miR-184 (Fig. 7) expression in wounded cells 
as relative to control cells, which is set to 1.0.  
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Figure 6. Expression of miR-205 in control vs. injured HCECs.  
The expression of miR-205 increased by 57% 1h after scratch 
wounding and by 96% 24h after wounding.  
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Figure 7. Expression of miR-184 in control vs. injured HCECs.  
There was no statistically significant change in the expression of miR-
184 between control and wounded cells at 1hr or 24hrs after wounding.   
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The 3’ UTR of KCNJ10 is a target for miRNA-205.  
 The above results led us to question whether KCNJ10 expression in 
HCECs is regulated by miR-205. By analyzing the sequence of miR-205 against 
the 3’-UTR of KCNJ10 using microRNA.org., based on methods by Betel et al., 
two possible targeting site for miR-205 were found to be located on the 3’ UTR of 
KCNJ10, from base 2874 to 2896, and from 2945 to 2966 [85, 86]. The seed 
sequence of miR-205 is underlined in Figure 8 below, the seed sequence, or 
region, is believed to determine miRNA target specificity. 
  
 
 
 
 
 
 
 
 
 
  
Figure 8. KCNJ10 mRNA is a potential target for miR-205.  
 
Two sequences from the 3’ UTR of KCNJ10 were found as matched binding 
sites for miR-205 seed sequence according to microRNA.org using the 
algorithm from Betel, 2010 [8]. The seed sequence of miR-205 is underlined.  
hsa-miR-205 
KCNJ10 (2874-2896) 
KCNJ10 (2945-2966) 
hsa-miR-205 3'-GUCUGAGGCCACCUUACUUCCU-5’ 
      :|||||||  
5'-AAGUGAGAUAGCUGAUGAAGGA-3' 
   
  
3'-GUCUGAGGCCACCUUACUUCCU-5’ 
    |||||||  
5'-AUAAAGAGGCAUUCAUGAAGGC-3'  
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Transfection of miR-205 mimic siRNA leads to increased wound healing in 
injured HCECs.  
 In HCECs transfected with miR-205 mimic via lentiviral delivery, a 
functional increase of miR-205 was observed. The upregulation of miR-205 lead 
to an increase in the regrowth percentage after scratch-injury as compared to 
HCECs transfected with control vectors 24 hours after injury. Figure 9 A-D show 
the temporal change at the wounding site between cells transfected with a 
control vector vs. miR-205 mimic . Figure 9E shows that the increase in healing 
percentage in mimic-transfected cells was significant.  
 
 
0.1mm 
A B 
C D 
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Expression miR-205 antagomir lead to delayed healing of HCECS.  
On the other hand, HCECs transfected with an exogenous siRNA designed to 
silence miR-205 action resulted in a functional decrease in the expression of 
miR-205 in HCECs. The downregulation of miR-205 lead to a decrease in the 
regrowth and healing rate after scratch-injury as compared to HCECs transfected 
with control vectors 24 hours after injury. 
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Figure 9. miR-205 positively affects HCEC wound healing.  
 
(A) Scratch wound injury generated in HCECs transfected with the control vector 
(pCDH) at 0hr. (B) Wound healing scratch site 24 hr after injury in control vector 
HCECs. (C) Scratch wound injury generated in HCECs transfected with miR-205 
mimic at 0hr. (D) increased healing observed in miR-205 mimic transfected 
HCECs 24 hr after scratch wound. (E) Significant higher regrowth percentage at 
24hr post injury in HCECs transfected with miR-205 mimic.   
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Effect of miR-205 mimic and antagomir on KCNJ10 expression in HCECs. 
The expression of KCNJ10 monomeric protein was decreased in HCECs 
transfected with a siRNA miR-205 mimic as compared to cells transfected with a 
blank vector control. Figure 10 shows the blot and graph of KCNJ10 expression 
as normalized to tubulin.  
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Figure 10. KCNJ10 expression in miR-205 mimic transfected HCECs. 
Western blot showing that monomeric KCNJ10 expression is significantly 
decreased in uninjured HCECs 48 hr after transfection of a siRNA miR-205 mimic, 
as compared to in HCECs receiving a control vector.  
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In contrast, KCNJ10 expression is higher in HCEC cells transfected with the 
pZip-miR-205 vector, which functionally leads to production of antagomir-205 that 
act to silence endogenous miR-205 (Figure 11).   
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Figure 11. KCNJ10 expression in HCECs transfected with control 
vector vs. antagomir-205 (anta-miR205).  
Blot showing monomeric KCNJ10 expression is higher in HCECs transfected 
with antagomir-205, which acts to silence endogenous miR-205 action. 
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DISCUSSION 
 
The majors findings of our present study are that: 1) KCNJ10 mRNA, 
which encodes for the inward-rectifying potassium channel Kir4.1, is expressed 
in human corneal epithelium;  2) that the expression of KCNJ10 mRNA is 
negatively associated with the process of wound healing in corneal epithelium, 
and 3) that KCNJ10 expression in corneal epithelia is subjected to regulation by 
microRNA-205 during wound healing. While previous studies have pointed to 
pathways involving microRNA mediation of potassium channels, we are the first 
to report of an Kir – microRNA relationship in the cornea epithelium.  
Our results are in line with those obtained by Yu et al. who first showed 
that miR-205 localized to wounded regions of the cornea using an in vivo animal 
model, and that it was shown to be positively correlated with corneal epithelial 
wound healing [73, 87]. In any case, we found that loss of function of miR-205 
could directly contribute to the impaired wound healing in HCECs through the 
loss of inhibition on KCNJ10, further indicating the indispensable role of miR-205 
in corneal wound repair.  
To be more specific, we find that higher KCNJ10 expression is associated 
with delayed healing rates after scratch wounding of HCECs, but that functional 
miR-205 works to inhibit KCNJ10 and therefore promote corneal wound healing. 
This is supported by the previous finding by Lin et al. at New York Medical 
College that when 500nM BaCl2, a Kir-specific K+ channel blocker, was added to 
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the medium of HCECs transfected with an miR-205 antagomir, the impaired 
healing, which had been caused by the anta-miR-205, was significantly relieved 
(data not published), and that healing was restored despite miR-205 antagomir 
expression.  
Our results show that KCNJ10 as being significantly and very quickly 
modulated by changes in miRNA-205 levels, which suggest a direct pathway of 
interaction between the two. In addition, the microRNA.org sequence analysis 
show two sequences on the 3’UTR of KCNJ10 that area complimentary to the 
seed sequence of miR-205. Together, the results strongly suggest that KCNJ10 
mRNA is a direct target of miRNA-205.  
Because miR-205 has been previously shown to accelerate migration by 
targeting SHIP2 expression in wounding keratinocytes, we initially speculated 
that it may have a wide range of target genes, especially given its wide 
distribution across epithelial types. Thus, its functional significance may be 
broadly involved in stimulating all three stage of corneal wound healing. On the 
other hand, we find it interesting that the most abundant miRNA of the cornea, 
miR-184, is not seemingly  uninvolved in wound healing. Given that it is much 
more tissue-specific than miR-205, and that the processes of cellular turnover 
and of wound healing is so intrinsic to corneal epithelia, the role of miR-184 
makes for an interesting puzzle.  
The results, which indicate that an miR-205 mimic can stimulate wound 
closure in HCECs, suggest that this is achieved through an increase in the 
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inhibition of KCNJ10 transcription. This would seemingly support previous papers 
which have reported Kir4.1 channels under inhibition in association with glial cell 
injury and healing [12]. Still unknown, however, is the mechanism by which 
inhibition of KCNJ10 translates into better healing. One possibility is associated 
with the process of depolarization, which has been shown to increase wound 
healing [70]. Since Kir4.1 is a weak rectifier, miR-205-induced inhibition of 
KCNJ10 would logically reduce the K+ leak, increase the positive intracellular 
charge, and lead to depolarization, which in turn can activate the V-gated Ca2+ 
channels, which can then sets off a cascade of intracellular signaling changes 
associated with proliferation and cytoskeletal changes. Studies of Ca2+ 
regulation in corneal wound healing is rather limited, and our results point to this 
as an interesting hypothesis.  
The prompt closure and healing of wounds in the cornea, as well as other 
barrier epithelia, is critical, as delays in healing can leave the cornea vulnerable 
to a host of complications that can threaten vision. Regulatory molecules 
associated with cornea healing are therefore always of clinical and 
pharmaceutical interest. While we demonstrated, in vitro, that modulating miR-
205 expression can affect the rate of healing. However, two caveats come to 
mind when discussing the upregulation of miR-205. First, its lack of organ 
specificity and broadness of distribution, and second, that as with any molecules 
that promote growth and hinder apoptosis, a balance is essential, and when it is 
tipped too heavily to the side of growth and proliferation, the result is often a loss 
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of control altogether, and a rise in malignancies. In fact, the majority of studies on 
miR-205 to date is in regard to its role in regulating tumor proliferation [73].   
Along the same line, Kir channels are also ubiquitously expressed throughout the 
body. A glance of table 1 remind us of their systemic effects. Tissue non-
specificity, combined with temporal and spatial controls in vivo make the clinical 
study and treatment of channelopathies a continuing challenge. 
 
In Conclusion 
A tendency exists in the learning of cellular processes whereby complex 
and dynamic interactions occurring on cell membranes are operatively divided 
neatly into two bins – one involving ions and channels, and the other involving 
ligands and receptors. While we have a good understanding of the latter – more 
traditional growth factor-mediated intracellular signaling; the former – an entire 
class of potential effectors and signaling molecules that are associated with ionic 
and electrical aspects of the cell, receives much less focus. Although studies 
dating back to the 1960s have shown that cells with a negative RMP rarely enter 
mitosis, little more is known today about the link between electric currents and 
cellular growth and proliferation [12]. We chose to explore the role that potassium 
and one of its channels plays in the story, using human corneal epithelial cells, 
and discovered microRNAs as potential modulators in the process of corneal 
healing. A story that, all in all, serves to elegantly emphasize the complexity of 
cellular control and regulation.  
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